CAI Q4 2018 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$116M+22.9% YoY

Gross Profit

$57M49.5% margin

Operating Income

$39M33.6% margin

Net Income

$19M16.8% margin

EPS (Diluted)

$1.01

QoQ Revenue Growth

+0.1%

Cash Flow

Operating Cash Flow

$40M

Free Cash Flow

-$243M

Stock-Based Comp.

$766,000

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$2.3B

Stockholders' Equity

$701M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$116M	$94M	+22.9%
Gross Profit	$57M	$49M	+15.8%
Operating Income	$39M	$34M	+15.5%
Net Income	$19M	$37M	-46.9%